Filing metadata

Accession number
0001140361-22-024164
Form type
Form 4
Filer
Atara Biotherapeutics, Inc.
CIK
CIK 1604464
Filed
Jun 27, 2022
Reporting period
Jun 23, 2022
Description
Insider transaction

Explore SEC Filings Hub